46
Participants
Start Date
December 10, 2024
Primary Completion Date
December 10, 2026
Study Completion Date
December 20, 2026
Levodopa/carbidopa
A dopamine precursor, was first developed for the treatment of PD in the 1960s and continues to be the most-effective therapeutic agent for PD
Fexofenadine
Fexofenadine is a second-generation antihistamine that does not penetrate the CNS and has the least CNS side effects among the second-generation antihistamines
RECRUITING
Tanta University, Tanta
Tanta University
OTHER